Established
Semaglutide
GLP-1 receptor agonist. Ozempic, Wegovy, Rybelsus
Evidenza tat-testi għal kull mediċina, bil-data ta' waqfa li l-marketing tendejna li jħalli barra.
Established
GLP-1 receptor agonist. Ozempic, Wegovy, Rybelsus
Established
Dual GIP / GLP-1 receptor agonist. Mounjaro, Zepbound
Established
GLP-1 receptor agonist. Victoza, Saxenda
Established
GLP-1 receptor agonist. Trulicity
Promising
GLP-1 receptor agonist, oral. Rybelsus
Popular but weak
Unapproved compounded preparation. Various, unbranded
Intermittent fasting, time-restricted eating and meal timing, judged on the trial data.
Energy expenditure, insulin resistance and metabolic adaptation, without the folklore.
Diets, drugs, behaviour and maintenance — ranked by the strength of the evidence behind them.
Sleep, circadian rhythm and the wearables that claim to measure both.
Din il-paġna ġiet tradotta awtomatikament mill-Ingliż. Il-citazzjonijiet u n-numri mhumiex mibdula. Aqra l-original Ingliż jekk xi ħaġa taqra b'mod stramb. Aqra l-original Ingliż